SriramVennetiMD

Neuropathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Venneti?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Sriram Venneti, MD is a board certified pathologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan and Pennsylvania. He is affiliated with University of Michigan Medical Center.

University of Pennsylvania Health SystemFellowship, Neuropathology, 2009 - 2011
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2007 - 2009
Bangalore Medical CollegeClass of 1998

PubMed

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
Daniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea, Marisol Gonzalez-Huarriz, Andrea Lacalle
Neuro-Oncology. 2024-08-05
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma.
Erik R Peterson, Peter Sajjakulnukit, Andrew J Scott, Caleb Heaslip, Anthony Andren
Cancer & Metabolism. 2024-04-09
1 citations
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma.
Stephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, Srinidhi Varadharajan, Brenden J Johnson
Cell Reports. 2024-01-23

Medical School Faculty Promotions Approved by U-M Board of RegentsMay 22nd, 2024
New Clues Toward Treating Paediatric Brain Tumours Harbouring Epigenetic MutationOctober 14th, 2021
New Clues Toward Treating Pediatric Brain Tumors Harboring Epigenetic MutationOctober 13th, 2021
Join now to see all